GlassScriptPhysician profile
Grigory Shtender
NPI 1952316614
$540.32
in general payments reported to CMS, 2019-2025
16 companies · $56.71 in 2025
The $56.71 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.40 · 2020: $39.59 · 2021: $220 · 2022: $92.04 · 2023: $27.41 · 2024: $69.79 · 2025: $56.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $149.43 | 2019-2022 | |
| Abbvie INC. | $55.88 | 2021-2022 | |
| Smith+Nephew, INC. | $41.17 | 2025 | Grafix Pl |
| Kowa Pharmaceuticals America, INC. | $39.23 | 2019-2022 | |
| Irhythm Technologies, INC. | $35.27 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $34.52 | 2024 | Wegovy, Saxenda |
| Corium, LLC | $27.41 | 2023 | Azstarys |
| Merck Sharp & Dohme LLC | $22.89 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.16 | 2022 | |
| Vistapharm, INC. | $18.52 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.10 | 2021 | |
| Endo Pharmaceuticals INC. | $16.86 | 2021 | |
| Boston Scientific Corporation | $16.55 | 2020 | |
| Vanda Pharmaceuticals INC. | $15.54 | 2025 | Hetlioz, Fanapt |
| Currax Pharmaceuticals LLC | $15.24 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grigory Shtender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.